Benefit of Transcutaneous Auricular Vagus Nerve Stimulation in Improving Quality of Life in First Line Treatment of Ovarian Cancer:

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
Impact of stimulation of parasympathetic activity by transcutaneous auricular vagus nerve stimulation (taVNS) on quality of life (QoL) relating to digestive symptoms in patients undergoing first-line treatment for ovarian cancer, as compared to shame taVNS
Epistemonikos ID: 7e45f4258acc6729dba1771bcbf8ff5444fcae92
First added on: Mar 01, 2025